Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies GlobeNewswire December 03, 2025 SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based […]

Protara Therapeutics Announces Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naive NMIBC Patients GlobeNewswire December 03, 2025 TARA-002 demonstrates 72% complete response rate at any time in BCG-Naive patients TARA-002 demonstrates a 69% complete response rate at the 6-month landmark and a 50% complete response rate at the 12-month landmark in

Catheter Precision Secures Tender From Leading Hospital in Hungary GlobeNewswire December 03, 2025 FORT MILL, S.C., Dec. 03, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK), a leading U.S.-based medical device company focusing on advanced solutions in the cardiac electrophysiology market, is proud to announce that its VIVO(TM) system has successfully secured a

MoneyHero Group Expands Hong Kong Digital Asset Wealth Product Offerings in Collaboration with HashKey Group GlobeNewswire December 03, 2025 HONG KONG, Dec. 03, 2025 (GLOBE NEWSWIRE) — MoneyHero Limited (NASDAQ: MNY) (“MoneyHero” or the “Company”), a leading tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast

VitalEdge Launches Insights Agent to Elevate Data-Driven Decision Making for Heavy Equipment Dealers Insights Agent Combines VitalEdge Data and Microsoft Copilot AI to Transform Dealer Operations GlobeNewswire December 03, 2025 CARY, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) — VitalEdge Technologies, the leading global provider of dealer management solutions for heavy equipment dealers, today announced the

Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC(TM) Neurostimulation Console in Alzheimer's Disease Program FDA feedback provides clear framework for Nexalin's planned U.S. Pilot Study and supports a potential De Novo pathway for the Gen-2 SYNC(TM) device in Alzheimer's disease GlobeNewswire December 03, 2025 HOUSTON, TX, Dec. 03, 2025 (GLOBE NEWSWIRE) — Nexalin Technology,

AmpliTech Group Receives Nearly $5 Million in Follow-On Orders From LOI Customers Company Provides Business Update as ORAN 5G, Satcom, and Private 5G Programs Progress GlobeNewswire December 03, 2025 HAUPPAUGE, N.Y., Dec. 03, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (NASDAQ: AMPG) (“AmpliTech” or the “Company”) today announced that it has received nearly US$5 million

Country Music Artist Superstar Blake Shelton Joins “The Michael Waddell Podcast” Shelton and Waddell Trade Songs and Stories in New Podcast Episode GlobeNewswire December 03, 2025 DENVER, CO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Country music artist, TV personality, and outdoorsman, Blake Shelton, joins Michael Waddell on the latest The Michael Waddell Podcast, presented by

Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group GlobeNewswire December 03, 2025 MALVERN, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD),

RIX Industries Opens New Center of Excellence for Advanced Development Near Company Headquarters Benicia-based site strengthens collaboration, accelerates product development, and supports long-term growth strategy GlobeNewswire December 03, 2025 BENICIA, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — RIX Industries, a recognized leader in advanced gas compression, gas generation, and precision-engineered technologies, today announced the grand